PTEN and uterine cancer: In contrast to Foxa2, Foxa2/Pten mice developed aggressive bulky uterine cancers by 1 year of age, resulting in greatly accelerated mortality (P < 0.0001, Foxa2/Pten vs. either single KO) (Figure 4, A and B).